IP Library Assignment 044088/0486
Patent Assignment
Reel/Frame 044088/0486

Assignment of Assignor's Interest

Recorded: 2017-11-10 Pages: 11
Assignors
WESTERGAARD, MAJKEN
Executed: 2006-06-19
THRUE, CHARLOTTE A.
Executed: 2006-06-07
RASMUSSEN, FRANK W.
Executed: 2006-06-14
HANSEN, HENRIK F.
Executed: 2006-06-14
Assignee
SANTARIS PHARMA A/S
BOGE ALLE 3, HORSHOLM, DK-2970, DENMARK
Covered Property (1)
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Patent: 9,938,527 →
Application: 15/243,646 →
Publication: US 2016/0355819
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 10, 2017
From: SANTARIS PHARMA A/S
To: ENZON, INC.
Reel/Frame 044088/0512 →
Assignment of Assignor's Interest Nov 10, 2017
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 044088/0538 →
Assignment of Assignor's Interest Nov 10, 2017
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 044088/0497 →
Change of Name Nov 10, 2017
From: SANTARIS PHARMA A/S
To: ROCHE INNOVATION CENTER COPENHAGEN A/S
Reel/Frame 044419/0290 →
Assignment of Assignor's Interest Nov 10, 2017
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 044088/0517 →
Assignment of Assignor's Interest Nov 10, 2017
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 044088/0520 →
Change of Name Nov 28, 2017
From: SANTARIS PHARMA A/S
To: ROCHE INNOVATION CENTER COPENHAGEN A/S
Reel/Frame 044740/0854 →